Physician profile
James E Phillips
NPI 1346206448
$2,977.39
in general payments reported to CMS, 2019-2025
32 companies · $419 in 2025
The $419 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,051 · 2020: $153 · 2021: $13.08 · 2022: $348 · 2023: $468 · 2024: $525 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,318 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,317.62 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $481.94 | 2019-2025 | Myrbetriq, Veozah |
| Pfizer INC. | $449.77 | 2019-2025 | |
| Glaxosmithkline, LLC. | $281.52 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $211.41 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Novo Nordisk INC | $183.42 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $142.05 | 2023-2025 | Rexulti |
| Abbvie INC. | $136.43 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $117.54 | 2024-2025 | Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.89 | 2019-2024 | Ofev, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $105.48 | 2019-2024 | Xifaxan, Trulance |
| Amgen INC. | $102.28 | 2019-2025 | Repatha, Repatha, Otezla |
| E.R. Squibb & Sons, L.L.C. | $91.48 | 2019-2025 | Eliquis, Camzyos |
| Amarin Pharma, INC. | $85.14 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $82.35 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $77.68 | 2024-2025 | Cologuard Collection Kit |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $51.71 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $25.62 | 2019-2022 | |
| Indivior INC. | $21.37 | 2019 | |
| Lundbeck LLC | $18.60 | 2023 | Rexulti |
| Xeris Pharmaceuticals, INC. | $18.19 | 2024 | Gvoke Hypopen |
| Bausch Health US, LLC | $17.45 | 2019 | |
| Cook Medical LLC | $17.02 | 2023 | Cook |
| Vivaquant INC, Dba Rhythm Express | $16.68 | 2024 | Rhythm Express |
| Orexo US, INC. | $16.17 | 2019 | |
| Seqirus USA INC | $15.44 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Amneal Pharmaceuticals LLC | $14.72 | 2023 | Unithroid |
| Si-Bone, INC. | $14.43 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $14.30 | 2023 | Livalo, Seglentis |
| Sanofi Pasteur INC. | $14.30 | 2019 | |
| Merck Sharp & Dohme LLC | $13.08 | 2021 | |
| Vanda Pharmaceuticals INC. | $12.70 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.